Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
NCT ID: NCT02448550
Last Updated: 2018-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
250 participants
INTERVENTIONAL
2015-05-31
2016-06-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antithrombotic Regimens and Outcome
NCT00448461
How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
NCT01519518
Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy
NCT06861374
Bivalirudin in Acute Myocardial Infarction
NCT02897037
Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI
NCT04475835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bivalirudin
Bivalirudin will be used for PCI with bailout glycoprotein 2b3a inhibitor use permitted.
Bivalirudin
unfractionated heparin
Unfractionated heparin will be used for PCI with bailout glycoprotein 2b3a inhibitor use permitted.
Unfractionated heparin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bivalirudin
Unfractionated heparin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18 years or older.
Exclusion Criteria
2. Emergency cardiac catheterization for ST-segment elevation myocardial infarction.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KP-RRC-CE1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.